A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2)
Geven, Christopher, Blet, Alice, Kox, Matthijs, Hartmann, Oliver, Scigalla, Paul, Zimmermann, Jens, Marx, Gernot, Laterre, Pierre-François, Mebazaa, Alexandre, Pickkers, PeterVolume:
9
Language:
english
Journal:
BMJ Open
DOI:
10.1136/bmjopen-2018-024475
Date:
February, 2019
File:
PDF, 393 KB
english, 2019